Moving Forward into the New Era of HSCT and Cellular Therapy
Today 2024.11.21 D-End
Today 
Moving Forward into the New Era of HSCT and Cellular Therapy
|
[OP01] Oral Presentation 1: ALL |
Room A | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Min Kyoung Kim (Yeungnam University College of Medicine, Korea) Ho Sup Lee (Kosin University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Clinical Implication and Long-term Survival Outcome of Second Allogeneic HCT in Adult Patients with Relapsed Acute Lymphoblastic Leukemia before and after the Era of Novel Immunotherapeutic Agents Daehun Kwag (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Optimization of Pre-Transplant Conditioning for Haploidentical Donor Transplantation in Adult Acute Lymphoblastic Leukemia: Interim Phase 2 Results of TBI-Augmented Reduced Toxicity Regimen Incorporating ATG/PTC Jaehyun Ahn (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Selection of Candidates for Allogenic Hematopoietic Stem Cell Transplantation with T-Lymphoblastic lymphoma by Comparative Study with T-Acute Lymphoblastic Leukemia Tong Yoon Kim (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Optimization of TBI-Based Myeloablative Conditioning Regimen Incorporating ATG and PTCY in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation: Historical Comparison with TBI/CY Jongseo Lee (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Korean Real-World Experience of Blinatumomab for 8 Years Regarding Predictive Factors Including Lymphocyte Kinetics for Response and Survival Outcome in Adult Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Seonghan Lee (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | Real-World Experiences of Inotuzumab Ozogamicin in Adult Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Jae Ho Yoon (The Catholic University of Korea, Korea) | ||
|
[OP02] Oral Presentation 2: Multiple Myeloma |
Room B | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Jae Hoon Lee (Gachon University College of Medicine, Korea) Kihyun Kim (Sungkyunkwan University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Impact of Tandem Autologous Stem Cell Transplantation in Multiple Myeloma Patients with MRD Positivity after First Transplantation, CARE-MM Study-2401 Sieun Oh (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | CD4 Cytotoxic T Cells Promote Antitumor Immunity in Multiple Myeloma Sojeong Kim (Yonsei University College of Medicine, Korea) | ||
| 09:20-09:30 | Discoidin Domain Receptor 1 (DDR1) is Associated with Treatment Outcomes in Multiple Myeloma (MM) after Autologous Stem Cell Transplantation Ji-Young Lim (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Mezigdomide plus Tazemetostat and Dexamethasone for Relapsed or Refractory Multiple Myeloma: Preliminary Results from the CA057-003 Trial Paul Richardson (Dana-Farber Cancer Institute, USA) | ||
| 09:40-09:50 | Evaluating the Efficacy and Safety of Immunotherapeutic T-Cell Engagers in Relapsed/Refractory Multiple Myeloma: A Real-World Comparison Data Analysis Mimicking RCT Sung-Soo Park (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | High B-cell Maturation Antigen Surface Expression on Myeloma Cells is Associated with Poor Survival Outcomes in Patients with Multiple Myeloma Suhyeon Hwang (Yonsei University College of Medicine, Korea) | ||
|
[OP03] Oral Presentation 3: AML |
Room C | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Inho Kim (Seoul National University College of Medicine, Korea) Seong Hyun Jeong (Ajou University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Early Prediction of Hypomethylating Agent Based Therapy Outcome in Elderly Myeloid Disease Patients: A Geriatric Functional Assessment Approach Mihee Kim (Chonnam National University Medical School, Korea) | |
| 09:10-09:20 | Diagnostic NGS Panel-Based Serial Measurable Residual Disease Monitoring as a Prognostic Indicator in Acute Myeloid Leukemia Patients Jae-Sook Ahn (Chonnam National University Medical Schoo, Korea) | ||
| 09:20-09:30 | Role of Allogeneic Stem Cell Transplantation in FLT3-ITD Mutated AML Patients Treated with Midostaurin: A Comparative Analysis with Standard Chemotherapy Kyoung Il Min (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Transplantation Outcomes after Venetoclax-Decitabine Compared to Conventional Chemotherapy as an Induction Therapy: A Propensity Score Matched Cohort Analysis Ka Young Kim (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Phase I Study to Evaluate Safety of VT-Tri after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML) Ki-Hyun Park (ViGenCell, Korea) | ||
| 09:50-10:00 | Post-Transplant Outcomes in FLT3-ITD Mutated Acute Myeloid Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Following Gilteritinib Treatment Daehun Kwag (The Catholic University of Korea, Korea) | ||
|
[OP04] Oral Presentation 4: Post-HCT Complications |
Room D | ||
|---|---|---|---|
| Date & Time | September 26 (Thu), 09:00-10:00 | ||
| Chair(s) |
Hyo Jung Kim (Hallym University College of Medicine, Korea) Yeon Jung Lim (Chungnam National University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Risk Factors and Prognosis of Invasive Fungal Disease Following Hematopoietic Stem Cell Transplantation in 1076 Pediatric Patients Jiaming Yu (Shenzhen Children's Hospital, China) | |
| 09:10-09:20 | Korean Real-World Data of Defibrotide for Treatment of Adult Patients who Developed Severe Hepatic VOD/SOS after Allogeneic Hematopoietic Cell Transplantation Jae Ho Yoon (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Mesenchymal Stem Cells Preconditioned with a TLR5 Agonist Enhanced Immunoregulatory Effect through M2 Macrophage Polarization in a Murine Graft-versus-Host Disease Model Junseok Lee (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Efficacy and Safety of Defibrotide for Pediatric Veno-occlusive Disease/Sinusoidal Obstruction Syndrome (VOD/SOS) - A Single Center Experience Shu-Wei Chou (National Taiwan University Hospital, Taiwan) | ||
| 09:40-09:50 | Aerosolized Pentamidine is an Effective Prophylaxis for Pneumocystis jiroveci Pneumonia in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation Ga-Young Song (Chonnam National University Medical School, Korea) | ||
| 09:50-10:00 | Exploring Risk Factors for Oral Mucositis in Lymphoma and Myeloma Patients Post-HSCT Ye Eun Oh (The Catholic University of Korea, Korea) | ||
|
[PL01] Plenary Session 1: State of the Art in Cellular Therapy & Immunotherapy September 26 (Thu), 10:40-12:00 |
Room A | |
|---|---|---|
| Chair(s) | Ki Woong Sung (Sungkyunkwan University School of Medicine, Korea) | |
Expanding Horizons of CAR T-Cell Therapy through Genome Editing
UCL Great Ormond Street Institute of Child Health, UK
Innovative Cellular Immunotherapy: Harnessing NK Cells, T Cells, and CAR-based Therapies for Cancer Treatment
Department of Companion and Laboratory Animal Science, Kongju National University, Korea
|
[LS01] Luncheon Symposium 1 (Johnson & Johnson): Diagnostic and Treatment Strategies for Newly Diagnosed Amyloid Light Chain (AL) Amyloidosis September 26 (Thu), 12:10-12:50 |
Room A | |
|---|---|---|
| Chair(s) | Hyeon-Seok Eom (National Cancer Center, Korea) | |
Paving the Future of AL Amyloidosis Treatment with Daratumumab-Based Treatment
National and Kapodistrian University of Athens School of Medicine, Greece
|
[LS02] Luncheon Symposium 2 (Sanofi Aventis Korea) September 26 (Thu), 12:10-12:50 |
Room B | |
|---|---|---|
| Chair(s) | Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) | |
New Chapter of cGvHD Therapeutics: Belumosudil
Princess Margaret Cancer Centre, Canada
|
[LS03] Luncheon Symposium 3 (Gilead Science Korea Ltd.): Invasive Fungal Infection September 26 (Thu), 12:10-12:50 |
Room C | |
|---|---|---|
| Chair(s) | Sung-Hyun Kim (Dong-A University College of Medicine, Korea) | |
Invisible Invaders: All Things to Know about Fungal Infection in Hematology
Charité - Universitätsmedizin Berlin, Germany
|
[LS04] Luncheon Symposium 4 (Kyowa Kirin Korea): Efficacy and Safety of Romiplostim in First-Line Treatment of Severe Aplastic Anemia September 26 (Thu), 12:10-12:50 |
Room D-1 | |
|---|---|---|
| Chair(s) | Jong Wook Lee (Hanyang University Medical Center, Korea) | |
From Second-Line to First-line: The Evolving Role of Romiplostim in Severe Aplastic Anemia Management
Sungkyunkwan University School of Medicine, Korea
|
[LS05] Luncheon Symposium 5 (AbbVie Korea): Paradigm Shift of Unfit AML Patient Treatment with Venetoclax? September 26 (Thu), 12:10-12:50 |
Room D-2 | |
|---|---|---|
| Chair(s) | Hee-Je Kim (The Catholic University of Korea, Korea) | |
How I Manage of Unfit AML Patients with Venetoclax for Long-term Survival
Seoul National University College of Medicine, Korea
|
[PL02] Plenary Session 2: Recent Advances in Transplantation Research September 26 (Thu), 13:00-14:20 |
Room A | |
|---|---|---|
| Chair(s) | Jong Wook Lee (Hanyang University Medical Center, Korea) | |
Exploring the Influence of the Microbiome on Hematopoiesis and Immune Reconstitution
Fred Hutchinson Cancer Center, USA
Unraveling the Significance of Germline Predisposition Mutations in MDS prior to Transplantation
University College London Hospitals NHS Foundation Trust, UK
|
[JS01] Joint Symposium 1: ASTCT-KSBMT: Real-World Experiences and New Considerations of CAR-T Therapy in Lymphoid Malignancy September 26 (Thu), 14:30-16:00 |
Room A | |
|---|---|---|
| Chair(s) |
Je-Jung Lee (Chonnam National University Medical School, Korea) Stanley Riddell (Fred Hutchinson Cancer Center, USA) |
|
Strategies to Mitigate CAR T-Cell-Associated Cytokine Release Syndrome and Neurologic Toxicity
Fred Hutchinson Cancer Center, USA
Real-World Outcomes with CAR T-Cell Therapy for Lymphoid Malignancies
University of Chicago, USA
Real-World Data of CAR-T in Refractory Lymphoma in Korea
Sungkyunkwan University School of Medicine, Korea
|
[SS01] Scientific Session 1: Unraveling the Pathogenesis of Tissue Changes Post Transplantation September 26 (Thu), 14:30-16:00 |
Room B | |
|---|---|---|
| Chair(s) |
Sung-Soo Yoon (Seoul National University College of Medicine, Korea) Myung Geun Shin (Chonnam National University Medical School, Korea) |
|
Role of Tissue Niches in Acute GI-GVHD Revealed by Spatial Transcriptomics
Massachusetts General Hospital, USA
Endotheliopathies after Transplant and Immune Therapies in Hematologic Malignancy, with a Focus on the Evolving Role of Defibrotide, Including Its Potential in the Endotheliitis of COVID-19
Dana-Farber Cancer Institute, USA
Leukemia Immune Escape in Posttransplantation Relapses: From Biology to Personalized Medicine (And Back)
IRCCS San Raffaele Scientific Institute, Italy
|
[SS02] Scientific Session 2: Issues with Optimal Donor and Graft September 26 (Thu), 14:30-16:00 |
Room C | |
|---|---|---|
| Chair(s) |
Jong Ho Won (Soonchunhyang University College of Medicine, Korea) Ho Joon Im (University of Ulsan College of Medicine, Korea) |
|
The Optimization for T-Cell Replete Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital, China
PBSCT Using Posttransplant Cyclophosphamide from HLA-Matched and 1-2 Allele Mismatched Donor
Hokkaido University, Japan
Strategies to Enhance Graft Performance in Cord Blood Transplantation
The University of Tokyo, Japan
|
[ES01] Education Session 1: Expanding Transplant Outcomes Research Opportunities through AI September 26 (Thu), 14:30-16:00 |
Room D | |
|---|---|---|
| Chair(s) |
Ho-Jin Shin (Pusan National University School of Medicine, Korea) Byung Sik Cho (The Catholic University of Korea, Korea) |
|
Assisting Treatment Selection Based on Big Data and Machine Learning
Department of Chemical Engineering, Hongik University, Korea
Strategies for Integrating ChatGPT and Generative AI into Clinical Studies
Department of Surgery, Seoul National University College of Medicine, Korea
Machine Learning Applications in Hematopoietic Cell Transplantation
University of Ulsan College of Medicine, Korea
|
[JS02] Joint Symposium 2: JSTCT-KSBMT: Current Aging Landscape and Considerations for HSCT in the Elderly September 26 (Thu), 16:40-18:20 |
Room A | |
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Takanori Teshima (Hokkaido University, Japan) |
|
Aging Landscape and Pre-Transplantation Considerations for Elderly Patients in Japan
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Japan
Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Japan
Toranomon Hospital, Japan
Geriatric Functional Assessments and Their Utility for Standard Intensive Chemotherapy and HSCT
The Catholic University of Korea, Korea
Transplantation Strategies and Outcome of Elderly Patients with Acute Leukemia in Korea
Kyungpook National University School of Medicine, Korea
|
[SS03] Scientific Session 3: HSCT and Cellular Therapies for Lymphoid Malignancies September 26 (Thu), 16:40-18:10 |
Room B | |
|---|---|---|
| Chair(s) |
Hoon Kook (Chonnam National University Medical School, Korea) Deok Hwan Yang (Chonnam National University Medical School, Korea) |
|
Choosing a CAR for Relapsed/Refractory DLBCL: Which CAR, for Whom, and When
Massachusetts General Hospital, Harvard Medical School, USA
Cellular Therapy for Primary and Secondary CNS Lymphoma: Transplantation? or CAR-T?
Sunnybrook Health Sciences Centre, Canada
Optimization of CAR-T Therapy for Acute Lymphoblastic Leukemia
Seoul National University College of Medicine, Korea
|
[SS04] Scientific Session 4: HCT in Bone Marrow Failure September 26 (Thu), 16:40-18:10 |
Room C | |
|---|---|---|
| Chair(s) |
Nack-Gyun Chung (The Catholic University of Korea, Korea) Seongsoo Jang (University of Ulsan College of Medicine, Korea) |
|
Interpretation of Germline Variants of IBMFS in Adult Patients with Hematologic Diseases
National Cancer Institute, USA
Hematopoietic Stem Cell Transplantation and Immunosuppressive Therapy in Aplastic Anemia
Jichi Medical University Saitama Medical Center, Japan
Genetic Diagnosis of Inherited Bone Marrow Failure Syndromes in the Era of Next-generation Sequencing
Sungkyunkwan University School of Medicine, Korea
|
[NS01] Nursing Session 1: Long-Term Follow-Up and Experience with Hematopoietic Stem Cell Transplant Patients I September 26 (Thu), 16:40-18:10 |
Room D | |
|---|---|---|
| Chair(s) | Minjin Choi (Samsung Medical Center, Korea) | |
Chasing after Blood Cancer for Forty Years
Konkuk University Medical Center, Korea
A 27-Year Journey as a Transplant Nurse "Empathy, Passion, and Resilience"
Asan Medical Center, Korea
A New Life Yet to Come: Twists and Turns in My Life as a Life Scientist and Cancer Patient
Department of Biological Sciences, KAIST, Korea
|
[SA01] Satellite Symposium 1 (Korea Otsuka Pharmaceutical): Treatment of Newly Diagnosed Ph+ ALL September 27 (Fri), 08:30-09:00 |
Room A | |
|---|---|---|
| Chair(s) | Seok Lee (The Catholic University of Korea, Korea) | |
Ponatinib and Chemotherapy for Adult Patients with Newly Diagnosed Ph+ ALL Based from the PhALLCON Trial
Tokai University School of Medicine, Japan
|
[OP05] Oral Presentation 5: AML, MDS, MPN |
Room A | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Soo-Mee Bang (Seoul National University College of Medicine, Korea) Sung Hwa Bae (Daegu Catholic University School of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | The Prognostic Impact of Allogeneic Stem Cell Transplantation on Patients with Myelodysplastic Syndromes/Neoplasms Wan-Hsuan Lee (National Taiwan University Hospital, Taiwan) | |
| 09:10-09:20 | Results of Allogeneic Stem Cell Transplantation in Advanced Myelofibrosis Jong Hyuk Lee (The Catholic University of Korea, Korea) | ||
| 09:20-09:30 | Pure Red Cell Aplasia in Acute Myeloid Leukemia Patients after ABO Mismatched HSCT So Yeon Park (The Catholic University of Korea, Korea) | ||
| 09:30-09:40 | Efficacy and Safety of Salvage Chemotherapy Regimens in Relapsed or Refractory Acute Myeloid Leukemia Hun Seok Choi (Yonsei University College of Medicine, Korea) | ||
| 09:40-09:50 | Real World Transplantation Outcomes of Myelofibrosis Treated with Pre-transplant Splenic Irradiation Yu-Sung Chang (National Taiwan University Hospital, Taiwan) | ||
| 09:50-10:00 | Venetoclax/Azacitidine Followed by Allogeneic Transplantation Is as Good as Intensive Chemotherapy Followed by Allogeneic Transplantation for Patients of AML at First Remission Su-Peng Yeh (China Medical University Hospital, Taiwan) | ||
|
[OP06] Oral Presentation 6: Pediatrics |
Room B | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Eun Sun Yoo (Ewha Womans University College of Medicine, Korea) Jun Eun Park (Korea University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Successful Outcomes of Haploidentical Family Donor Hematopoietic Cell Transplantation in Pediatric Severe Aplastic Anemia Suejung Jo (The Catholic University of Korea, Korea) | |
| 09:10-09:20 | Outcome of Allogenic Hematopoietic Stem Cell Transplantation in Leukodystrophies: A Single-Center Experience over 15 Years Hyun Jin Park (Seoul National University College of Medicine, Korea) | ||
| 09:20-09:30 | Comparable Outcome of Myeloablative Total Body Irradiation Conditioning and Chemo-conditioning in Pediatric Acute Lymphoblastic Leukemia Patients Undergoing First Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Korean Registry-Based Study Kyung Taek Hong (Seoul National University College of Medicine, Korea) | ||
| 09:30-09:40 | Feasibility of Tandem Conditioning-Based Myeloablative HSCT for Pediatric Patients with Relapsed/Refractory Myeloid Hematologic Malignancies Jae Won Yoo (The Catholic University of Korea, Korea) | ||
| 09:40-09:50 | Response-Adapted Consolidation Therapy Strategy for Patients with Metastatic High-risk Neuroblastoma: Results of the SMC NB-2014 Study Hee Won Cho (Sungkyunkwan University School of Medicine, Korea) | ||
| 09:50-10:00 | Introduction of Bone Marrow Transplantation in Children in Uzbekistan Khilola Rustamova (Scientific and Practical Center of Pediatric Oncology, Hematology and Immunology of Uzbekistan, Uzbekistan) | ||
|
[OP07] Oral Presentation 7: Basic Research and Others |
Room C | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Hye Lim Jung (Sungkyunkwan University School of Medicine, Korea) Yong Park (Korea University College of Medicine, Korea) |
||
| Speaker(s) | 09:00-09:10 | Graft-versus-Host Disease Prophylaxis with Post-Transplant Cyclophosphamide Better Preserves Regulatory T Cell Bu-Yeon Heo (Chungnam National University College of Medicine, Korea) | |
| 09:10-09:20 | The Expression of TIM3 on Marrow-Infiltrating T cells Is Increased in Patients with Blood Cancers Who Relapse Early after Hematopoietic Stem Cell Transplantation Thi Thuy Duong Pham (Chungnam National University College of Medicine, Korea) | ||
| 09:20-09:30 | Mesenchymal Stem Cell-Derived Exosomes for Enhanced Proliferation of CD34+ Cells Kunye Kwak (Korea University College of Medicine, Korea) | ||
| 09:30-09:40 | Phase II Trial of Imatinib Mesylate in Patients with Idiopathic Hypereosinophilic Syndrome Dong Hyun Kim (Seoul National University College of Medicine, Korea) | ||
| 09:40-09:50 | Low Dose Fludarabine Is an Effective Conditioning Treatment to Suppress Relapse Rate in PT-CY-Based Haploidentical Peripheral Blood Stem Cell Transplantation Jinhang Kim (The Catholic University of Korea, Korea) | ||
| 09:50-10:00 | Novel Mechanisms of Leukemogenesis: Genome Reorganization by TET Loss of Function Myunggon Ko (Ulsan National Institute of Science and Technology, Korea) | ||
|
[OP08] Oral Presentation 8: Lymphoid Malignancies and CAR-T |
Room D | ||
|---|---|---|---|
| Date & Time | September 27 (Fri), 09:00-10:00 | ||
| Chair(s) |
Seok-Goo Cho (The Catholic University of Korea, Korea) Jeong A Kim (The Catholic University of Korea, Korea) |
||
| Speaker(s) | 09:00-09:10 | Anti-BCMA Dual Epitope-Binding CAR-Marrow Infiltrating Lymphocytes (MILs) against Multiple Myeloma Manh Cuong Vo (Chonnam National University Medical School, Korea) | |
| 09:10-09:20 | CAR-T Therapy in Taiwan: Outcomes and Adverse Events from a National Registry Analysis Xavier Cheng-Hong Tsai (National Taiwan University Hospital, Taiwan) | ||
| 09:20-09:30 | Risk-Stratification for DLBCL Patients Receiving ASCT in the Era of New Targeted Drugs: A Real-World Study in China Wen-Xuan Huo (Peking University People's Hospital, China) | ||
| 09:30-09:40 | Single-cell RNA Analysis of Peripheral T Cells in Chronic Lymphocytic Leukemia Relapse after Chemotherapy or Allogeneic Transplantation Ho Cheol Jang (Chonnam National University Medical School, Korea) | ||
| 09:40-09:50 | Prognostic Factors and Treatment Outcome of Allo-SCT for Lymphoid Malignancy Hyungsoon Kim (Yonsei University College of Medicine, Korea) | ||
| 09:50-10:00 | Efficacy and Safety of Cytokine-Induced Killer Cells Infusion Combined with TRUXIMA as Post-Remission Therapy in Old Aged High-Risk Diffuse Large B Cell Lymphoma Patients Gi June Min (The Catholic University of Korea, Korea) | ||
|
[PL03] Plenary Session 3: New Horizons in the Treatment of Acute Myeloid Leukemia September 27 (Fri), 10:20-11:00 |
Room A | |
|---|---|---|
| Chair(s) | Hyeoung-Joon Kim (Chonnam National University Medical School, Korea) | |
New Horizons in the Treatment of Acute Myeloid Leukemia
The Catholic University of Korea, Korea
|
[PS01] Presidential Symposium: Future Perspectives of HSCT in the Cellular Immunotherapy Era September 27 (Fri), 11:00-11:40 |
Room A | |
|---|---|---|
| Chair(s) | Je-Jung Lee (Chonnam National University Medical School, Korea) | |
Future Perspectives of HSCT in the Cellular Immunotherapy Era
University Medical Center Hamburg-Eppendorf, Germany
|
[LS06] Luncheon Symposium 6 (BMS KOREA): Strategies to Optimize the Outcomes of Transplantation for Myelofibrosis September 27 (Fri), 11:50-12:30 |
Room A | |
|---|---|---|
| Chair(s) | Chul Won Jung (Sungkyunkwan University School of Medicine, Korea) | |
How to Optimize Outcomes of Transplant in Myelofibrosis?
Princess Margaret Cancer Centre, Canada
|
[LS07] Luncheon Symposium 7 (Pfizer Korea): Invasive Mold Infection September 27 (Fri), 11:50-12:30 |
Room B | |
|---|---|---|
| Chair(s) | Hee-Je Kim (The Catholic University of Korea, Korea) | |
Optimal Managing of IMD in the Haematology Unit: Role of Vfend®, Cresemba®
The Catholic University of Korea, Korea
|
[LS08] Luncheon Symposium 8 (Novartis Korea) September 27 (Fri), 11:50-12:30 |
Room C | |
|---|---|---|
| Chair(s) | Je-Hwan Lee (University of Ulsan College of Medicine, Korea) | |
Management of GVHD in 2024 - From Steroid-to-Steroid Sparing Approach
Vanderbilt University Medical Center, USA
|
[LS09] Luncheon Symposium 9 (MSD Korea) September 27 (Fri), 11:50-12:30 |
Room D-1 | |
|---|---|---|
| Chair(s) | Ho-Jin Shin (Pusan National University School of Medicine, Korea) | |
CMV Prophylaxis with Letermovir in Allo HSCT - Extended Use in High Risk Patients
National Cancer Center, Korea
|
[LS10] Luncheon Symposium 10 (Handok Inc.) September 27 (Fri), 11:50-12:30 |
Room D-2 | |
|---|---|---|
| Chair(s) | Jin Seok Kim (Yonsei University College of Medicine, Korea) | |
Remaining Unmet Needs in Current Treatment and a New Treatment Option in PNH
Royal Melbourne Hospital, Australia
|
[SS05] Scientific Session 5: Microbiota in Transplantation and Cell Therapy September 27 (Fri), 12:40-14:10 |
Room A | |
|---|---|---|
| Chair(s) |
Sang Kyun Sohn (Kyungpook National University School of Medicine, Korea) Joon Seong Park (Ajou University School of Medicine, Korea) |
|
Evaluating the Regulatory Mechanisms for the Impact of the Intestinal Microbiome on Chimeric Antigen Receptor T Cells
Stanford University, USA
Prolonged Gut Microbial Alterations in Post-Transplant Survivors of Allogeneic Hematopoietic Stem Cell Transplantation
Osaka University Graduate School of Medicine, Japan
Fecal Microbiota Transplantation in the Prophylactic Setting after Allogeneic Hematopoietic Cell Transplantation
Fred Hutch Cancer Center, USA
|
[SS06] Scientific Session 6: Optimizing Graft Engineering and Cell Therapy September 27 (Fri), 12:40-14:10 |
Room B | |
|---|---|---|
| Chair(s) |
Hyeon Jin Park (National Cancer Center, Korea) Duck Cho (Sungkyunkwan University School of Medicine, Korea) |
|
Haploidentical HCT for Neuroblastoma
University Children’s Hospital Tuebingen, Germany
Graft Engineering and Adoptive Cell Therapy
University of Ulsan College of Medicine, Korea
Modulating NK Cell Synapses for the Improvement of NK Cell Therapy
Department of Materials Science and Engineering, Seoul National University, Korea
|
[ES02] Education Session 2: The Clinical Role of HSCT in Patients with MPN September 27 (Fri), 12:40-14:10 |
Room C | |
|---|---|---|
| Chair(s) |
Chul Won Choi (Korea University Guro Hospital, Korea) Sung-Yong Kim (Konkuk University School of Medicine, Korea) |
|
Considerations before HSCT for Patients with MF
The Catholic University of Korea, Korea
Considerations About HSCT for Patients with MF (Donor, Conditioning Regimen, Engraftment, GVHD Prophylaxis)
Seoul National University College of Medicine, Korea
Is HSCT Still the Effective Treatment for CML?
Soonchunhyang University College of Medicine, Korea
|
[SS07] Scientific Session 7: Innovations in Cellular Therapy and Beyond September 27 (Fri), 12:40-14:10 |
Room D | |
|---|---|---|
| Chair(s) |
Chang-Ki Min (The Catholic University of Korea, Korea) Hyeon-Seok Eom (National Cancer Center, Korea) |
|
Next-Generation Novel Therapies in Multiple Myeloma
Dana-Farber Cancer Institute, USA
CAR-19 Expressing Regulatory T cells to Enhance GVHD-free, Relapse-free Survival in Patients with High Risk CD19+ Hematological Malignancy: Rationale and Developmental Pathway
University of Minnesota, USA
CAR-T Cell Therapy in Gastrointestinal Cancers
Peking University Cancer Hospital & Institute, China
|
[JS03] Joint Symposium 3: EBMT-KSBMT: Disease-specific Issues and Transplantation Outcomes of CBT and HIDT September 27 (Fri), 14:20-16:00 |
Room A | |
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Anna Sureda (Catalan Institute of Oncology, Spain) |
|
Current Status of Alternative Donor Transplantation Compared to Conventional Donor: EBMT Perspectives
IRCCS San Raffaele Hospital, Italy
KIR-Mismatch and Transplantation Outcome in Myeloid vs. Lymphoid Disease
Chaim Sheba Medical Center, Israel
Outcome of Alternative Donor Transplantation in AML and MDS in Korea
Chonnam National University Medical School, Korea
Alternative Donor Hematopoietic Cell Transplantation (HCT): Korean Experiences and Optimization of Cord Blood and Haploidentical Donor HCT in Adult ALL
The Catholic University of Korea, Korea
|
[DS01] Debate Session 1: ASCT for Multiple Myeloma Patients with Chronic Kidney Disease September 27 (Fri), 14:20-16:00KorKorean-English |
Room B | |
|---|---|---|
| Chair(s) | Jin Seok Kim (Yonsei University College of Medicine, Korea) | |
No Upfront ASCT
Dong-A University College of Medicine, Korea
Upfront ASCT
Chungnam National University College of Medicine, Korea
|
[DS02] Debate Session 2: Upfront HSCT for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Children and Adolescents September 27 (Fri), 14:20-16:00KorKorean-English |
Room B | |
|---|---|---|
| Chair(s) | Kyung-Nam Koh (University of Ulsan College of Medicine, Korea) | |
Cons: Upfront HSCT Is Not Needed
Sungkyunkwan University School of Medicine, Korea
Pro: Upfront HSCT Is Needed
Yonsei University College of Medicine, Korea
|
[ES03] Education Session 3: Post-HSCT, Non-hematological Complication and Management September 27 (Fri), 14:20-15:50 |
Room C | |
|---|---|---|
| Chair(s) |
Jae-Yong Kwak (Jeonbuk National University Medical School, Korea) Hyoung Soo Choi (Seoul National University College of Medicine, Korea) |
|
Late Effect of Transplantation
Fujita Health University School of Medicine, Japan
Post-HSCT Psychological Impact and Care
Department of Psychiatry, Seoul National University College of Medicine, Korea
Fertility after Allogeneic Hematopoietic Stem Cell Transplantation
University of Ulsan College of Medicine, Korea
|
[SS08] Scientific Session 8: The 30th Anniversary Symposium of KMDP & CHSCB September 27 (Fri), 14:20-16:05 |
Room D | |
|---|---|---|
| Chair(s) |
Hong Ghi Lee (Konkuk University Medical Center, Korea) Yeun Jun Chung (The Catholic University of Korea, Korea) |
|
Opening Remark
Konkuk University Medical Center, Korea
Transplants from Unrelated Donors in the United States: Where We Are, Where We Are Going
Fred Hutch Cancer Center, USA
Transplants from Unrelated Donors in Europe: Where We Are and Where We Are Going
University Medical Center Hamburg-Eppendorf, Germany
Designing the Future of Unrelated Donor Registries and Transplantation - JMDP Perspective -
Keio University School of Medicine, Japan
Unrelated Donor Hematopoietic Stem Cell Transplantation in Korea
Sungkyunkwan University School of Medicine, Korea
Closing Remark
The Catholic University of Korea, Korea
|
[JS04] Joint Symposium 4: East Asia Collaborative Session: Autologous Transplantation Strategies for High-risk Myeloma in the East-Asian Countries September 27 (Fri), 16:30-18:10 |
Room A | |
|---|---|---|
| Chair(s) |
Je-Jung Lee (Chonnam National University Medical School, Korea) Chi-Cheng Li (Hualien Tzu Chi Hospital, Taiwan) |
|
Current Role of ASCT in Multiple Myeloma
Chonnam National University Medical School, Korea
Autologous Stem Cell Mobilization and Transplantation for Multiple Myeloma - Current Status and Future Perspectives in Japan -
Japanese Red Cross Medical Center, Japan
Current Status of ASCT and the Role of CAR-T Cell Therapy in Managing Myeloma in China
Peking University People's Hospital, China
Post-Transplant Maintenance Therapy in Patients with Multiple Myeloma in Taiwan
National Taiwan University Hospital, Taiwan
|
[SS09] Scientific Session 9: Advancements in AML and MDS September 27 (Fri), 16:40-18:10 |
Room B | |
|---|---|---|
| Chair(s) |
Yoo Hong Min (Yonsei University School of Medicine, Korea) Kyoo-Hyung Lee (Ewha Womans University College of Medicine, Korea) |
|
Base Editing of Surface Epitopes to Empower Cancer Immunotherapy and Beyond
Dana-Farber/Boston Children's Cancer and Blood Disorders Center, USA
Is AML Remission Induction Prior to alloHCT Necessary?
University Hospital Carl Gustav Carus Dresden, Germany
Salvage HSCT in AML: Strategies for Improvement
Seoul National University College of Medicine, Korea
|
[SS10] Scientific Session 10: Regulatory Status of Novel Cell and Gene Therapy September 27 (Fri), 16:40-18:10 |
Room C | |
|---|---|---|
| Chair(s) |
Hyoung Jin Kang (Seoul National University College of Medicine, Korea) So Ra Park (Regenerative Medicine Acceleration Foundation, Korea) |
|
Regulatory Science Updates for Advanced Biological Products in Korea
Cell&Gene Therapy Products Division/MFDS, Korea
Opportunities and Challenges on Clinical Translation of Cell & Gene Therapy in Korea
Regenerative Medicine Acceleration Foundation, Korea
From Lab to Bedside: Navigating FDA Regulations for Novel Cell Therapies in the US
Children's Hospital Colorado, USA
|
[ES04] Education Session 4: Back to the Basic - Guidelines of Hematopoietic Stem Cell Transplantation September 27 (Fri), 16:40-18:10 |
Room D | |
|---|---|---|
| Chair(s) |
Sung-Hyun Kim (Dong-A University College of Medicine, Korea) Jung Woo Han (Yonsei University College of Medicine, Korea) |
|
Vaccination Guidelines after Hematopoietic Cell Transplantation
Chonnam National University Medical School, Korea
Cytomegalovirus in Hematopoietic Cell Transplantation: Prophylaxis & Treatment
The Catholic University of Korea, Korea
Appropriate Screening for cGVHD
Kyungpook National University School of Medicine, Korea
|
[JS05] Joint Symposium 5: ISCT-KSBMT: Current Status and Future Prospect of Artificial Blood Products September 28 (Sat), 09:00-10:30 |
Room A | |
|---|---|---|
| Chair(s) |
Seong Kyu Park (Soonchunhyang University College of Medicine, Korea) Steve Oh (Independent Cell Therapy Leader, Singapore) |
|
Supercharging the Delivery of Gene Therapies with Red Blood Cells
Independent Cell Therapy Leader, Singapore
Technical Issues and Hurdles of In Vitro Derived Blood Products
Scottish National Blood Transfusion Service, UK
Manufacturing Blood Products Derived from Stem Cells
Department of Laboratory Medicine, Hanyang University College of Medicine; ArtBlood Inc., Korea
|
[SS11] Scientific Session 11: Beyond JAK Pathway in GVHD September 28 (Sat), 09:00-10:30 |
Room B | |
|---|---|---|
| Chair(s) |
Deog-Yeon Jo (Chungnam National University College of Medicine, Korea) Won-Sik Lee (Inje University College of Medicine, Korea) |
|
Defining a TCF1-Expressing Progenitor Allogeneic CD8+ T Cell Subset in Acute Graft-versus-Host Disease
Department of Immunology, Sungkyunkwan University School of Medicine, Korea
CSF-1R Inhibitor (Axatilimab) for Chronic GVHD
University Hospital Regensburg, Germany
PD-1H/VISTA Expressed on Host Myeloid Cells Limits Acute Graft-versus-Host Disease
Vanderbilt University, USA
|
[SS12] Scientific Session 12: Current Overview and Pragmatic Challenges in CAR-T Therapeutics September 28 (Sat), 09:00-10:30 |
Room C | |
|---|---|---|
| Chair(s) |
Seok Jin Kim (Sungkyunkwan University School of Medicine, Korea) Byung-Su Kim (The Catholic University of Korea, Korea) |
|
Conquering Tumor Heterogeneity with Engineered T Cell Therapies
Fred Hutchinson Cancer Center, USA
Changing the Treatment Landscape with CART Cells in Patients with B-Cell Lymphomas
Catalan Institute of Oncology, Spain
Practical Challenges in Korea
University of Ulsan College of Medicine, Korea
|
[JS06] Joint Symposium 6: TSBMT-KSBMT: Management of Early Transplantation Complications September 28 (Sat), 10:40-11:40 |
Room A | |
|---|---|---|
| Chair(s) |
Jae Ho Yoon (The Catholic University of Korea, Korea) Elifcan Aladag Karakulak (Hacettepe University, Türkiye) |
|
Prevention and Treatment Strategy of Acute GVHD in Türkiye
Hacettepe University, Türkiye
Preventive and Treatment Strategy of VOD and TA-TMA in Korea
The Catholic University of Korea, Korea
|
[SS13] Scientific Session 13: Transplantation in Pediatric Leukemia - For the Best Outcomes September 28 (Sat), 10:40-12:10 |
Room B | |
|---|---|---|
| Chair(s) |
Keon Hee Yoo (Sungkyunkwan University School of Medicine, Korea) Jae Wook Lee (The Catholic University of Korea, Korea) |
|
PTCy-Based Haploidentical HSCT in Pediatric Leukemia
Johns Hopkins University School of Medicine, USA
Optimizing Conditioning for Children and Adolescents with ALL
Goethe University Frankfurt, Germany
PTCy-Based Haploidentical HSCT for Pediatric AML
The Catholic University of Korea, Korea
|
[NS02] Nursing Session 2: Long-Term Follow-Up and Experience with Hematopoietic Stem Cell Transplant Patients II September 28 (Sat), 10:40-12:10 |
Room C | |
|---|---|---|
| Chair(s) | EunJung Joo (National Cancer Center, Korea) | |
Management of Pulmonary Complication
Department of Internal Medicine, The Catholic University of Korea, Korea
Health Rehabilitation Program for HSCT Patients
Department of Rehabilitation Medicine, Seoul National University College of Medicine, Korea
& Voting will be provided.